Skip to main content
Premium Trial:

Request an Annual Quote

Cellzome to Use BioSeek Platform in Inflammatory Diseases Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Tissue supply firm Asterand today said that its BioSeek subsidiary will provide its BioMap predictive human disease models to Cellzome for use in its inflammatory disease drug discovery projects.

The BioMap platform will be used to predict possible human clinical responses to small molecules identified by Cellzome using its own Kinobeads and Episphere screening and profiling technologies. The agreement is for two years.

"The BioMap platform will allow us to receive early insight into the human pharmacological and toxicological properties of our small molecules, enabling us to develop safer and more effective treatments for inflammation," Oliver Rausch, VP of Biology at Cambridge, UK-based Cellzome, said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.